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ABSTRACT  
Objective: Optimising uptake of colorectal cancer (CRC) screening is important to 
achieve projected health outcomes.  Population-based screening by flexible 
sigmoidoscopy (FS) was introduced in England in 2013 (NHS Bowel scope screening). 
Little is known about reactions to the invitation to participate in FS screening, as offered 
within the context of the Bowel scope programme.  We aimed to investigate responses 
to the screening invitation to inform understanding of decision-making, particularly in 
relation to non-participation in screening.  
Design:  Qualitative analysis of semi-structured in-depth interviews and written 
accounts.  
Participants and setting: People from 31 general practices in the North East and East 
of England invited to attend FS screening as part of NHS Bowel scope screening 
programme were sent invitations to take part in the study.   We purposively sampled 
interviewees to ensure a range of accounts in terms of beliefs, screening attendance, sex, 
and geographical location.  
Results: 20 screeners and 25 non-screeners were interviewed. Written responses 
describing reasons for, and circumstances surrounding, non-participation from a further 
28 non-screeners were included in the analysis. Thematic Analysis identified a range of 
reactions to the screening invitation, decision-making processes and barriers to 
participation. These include: a perceived or actual lack of need; inability to attend; 
anxiety and fear about bowel preparation, procedures or hospital; inability or reluctance 
to self-administer an enema; beliefs about low susceptibility to bowel cancer or 
treatment; understanding of harm and benefits. The strength, rather than presence, of 
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concerns about the test and perceived need for reassurance were important in the 
decision to participate for both screeners and non-screeners.  Decision-making occurs 
within the context of previous experiences and day-to-day life.  
Conclusions: Understanding the reasons for non-participation in FS screening can help 
inform strategies to improve uptake and may be transferable to other screening 
programmes.    
Strengths and limitations of this study 
1. Qualitative methods used within this study allowed an in-depth exploration of the 
contexts, decision-making processes and emotional reactions rooted within 
the reasons provided for non-participation in CRC screening.  
2. Our recruitment strategy allowed for anticipated difficulties in recruiting 
non-screeners, however, the overall response to our study invitation 
remained low.  
3. Purposive sampling ensured that we were able to include accounts from a 
full range of participants in terms of their beliefs, decision-making and 
attendance.  
4. Our sampling allowed us to compare a diverse range of accounts from 
screeners and non-screeners within and across research sites and screening 
centres, including participants living in the most deprived areas within the 
UK.   
5. Our sample did not include enough respondents from ethnic minority groups 
to draw conclusions about more specific cultural influences.  
 
INTRODUCTION  
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Colorectal cancer (CRC) screening is important in reducing CRC-related mortality.
1-3
 In 
England, a flexible sigmoidoscopy (FS) test at 55 years has been added to the existing 
faecal occult blood testing (FOBT) population-based CRC screening programme 
offered between 60 and 74 years.
4
. Since 2013, the FS programme, termed Bowel 
scope, has been progressively implemented across the United Kingdom (UK) through 
regional bowel screening centres. Each centre covers a geographical population which is 
served by a number of screening sites (endoscopy units). Each centre is expected to 
have at least one site offering FS screening by the end of 2016, with complete coverage 
of the English population expected around 3 years after that.  The primary purpose of 
FS screening is to prevent CRC by identifying and removing adenomas before they 
develop malignant changes. It has been shown to reduce both CRC mortality and 
incidence in the UK, 
1,5
 Europe and the USA.
6
   The effectiveness of any population-
based screening programme is reliant on high uptake. At 43.1%, CRC screening uptake 
is lower than breast or cervical cancer screening (even among women),
7
 and uptake for 
FS is lower than for FOBT.
4, 8
  Understanding the influences on decision-making and 
non-participation in FS screening is therefore important to help optimise projected gains 
in mortality and reduce health inequalities.    
A number of socio-demographic, ethnic, and sociological influences on FOBT 
screening participation have been identified.
9-14
 Intervention studies incorporating 
factors such as general practitioner endorsement,
15
 reminders and social networks 
have shown these can have a positive effect on uptake. However, the evidence is 
inconsistent 
16-17
 and effectiveness is likely to be, in part, influenced by the health 
care context in which the intervention is based.  The dynamics of decision-making for 
FS screening may be quite different, with its high technology, specialist-based 
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approach, a less proactive role required for participants and a different method of 
invitation. Qualitative research among participants in the UK FS Trial
1
 has 
identified that most of the effects of demographic and health variables on interest in 
participation are mediated by socio-cognitive variables,
18
 although actual uptake 
among interested participants is influenced more directly by demographics, health and 
stress.
19
  Non-participation is also reported to be influenced by avoidant attitudes 
towards screening, other health beliefs,20,21 fear
22
 and  deprivation.
23
  This research 
has been undertaken with people offered screening within a research trial context or 
has focused on intention rather than actual screening behavior.   A quantitative 
analysis of screening uptake in the first 14 months of the English Bowel scope 
screening programme identified independent effects of deprivation, gender and 
screening centre on screening participation.
7
 We sought to gain a more thorough 
understanding of the influences on screening participation by conducting an in-
depth exploration of the responses of members of the public to their invitation to the 
Bowel scope screening programme. By taking this approach we obtained their  
reflections on their actual decision-making and experiences,  their awareness and 
understanding of CRC and the contexts surrounding reasons for non-participation.  
METHODS  
Setting  
The study took place across two research sites (the North East England and East of 
England), chosen because of their diverse deprivation profiles and their location within 
areas covered by two of the first English pilot NHS Bowel scope screening centres.  The 
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study was provided a favourable ethical opinion by the NHS Bromley NRES 
Committee (14/LO/0207).  
Participant recruitment 
For each General Practice included in the screening programme, the NHS CRC 
screening hubs generate a letter inviting patients aged 55 years to attend for FS 
screening at their local Bowel scope screening centre.    Thirty one eligible General 
Practices (18 North East England; 13 East of England) agreed to mail study information 
explaining the aims of the study and a study sampling questionnaire to all patients 
invited for FS screening within the previous six months.   The Bowel scope screening 
invitation process takes eight weeks from initial contact to appointment date and no 
study information was sent to patients during this time to avoid influencing their 
decision-making.  Recruitment took place between March and December 2014.  
Participants were asked to return the sampling questionnaire directly to the study 
researchers indicating whether they wished to be contacted for a face-to-face interview. 
The sampling questionnaire gathered information on gender, ethnicity, screening 
attendance and a series of items to assess attitudes towards cancer, concerns about the 
FS test and current bowel symptoms. This information was used to purposively sample 
participants for interview, helping to ensure we interviewed people who had attended 
FS screening (screeners) and those who had not attended (non-screeners) including 
people with a range of attitudes, beliefs and reasons for attending and not attending 
screening. 
Study information was initially sent to 623 eligible patients. There were lower rates of 
questionnaire return among the non-screeners (36%) than the screeners (61%). To 
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adhere to the principles of qualitative purposive sampling
24
, after 5 months of 
recruitment we only sent recruitment material to non-screeners, thereby helping to 
ensure we recruited from this typically hard to reach group. At this stage study 
information was posted to a further 552 non-screeners in phases until we had 
interviewed 25 non-screeners and 20 screeners and no new themes were emerging from 
the participants accounts. 
The sampling questionnaire included an open question inviting written responses for 
reasons for non-attendance. By interviewing people who had undergone and not 
undergone screening, we were able to explore similarities and differences in beliefs and 
decision-making processes.  
Data collection 
Semi-structured, face-to-face interviews were undertaken in the participant’s home by 
NH and LB, both experienced post-doctoral qualitative researchers. Interviews were 
preceded by an explanation of the research, a reiteration that the researcher was not a 
member of the FS screening team or the GP practice. Written consent was obtained 
before the interview commenced. The semi-structured interview guide included general 
open ended questions on reasons for attending or not-attending screening, concerns 
about FS screening, understanding of colorectal cancer and views on screening within 
the NHS. Participant initiated topics were encouraged and pursued during the 
interviews. Additional interview prompts included knowledge, beliefs and previous 
experiences of cancer in general and cancer screening more specifically; practicalities, 
concerns and experiences associated with screening attendance and bowel preparations; 
and participation in other screening programmes.  Interviews lasted between 30-50 
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minutes and were audio recorded.  All written responses to an open ended question 
included within the sampling questionnaire (“Please let us know below if there were any 
other reasons or circumstances which meant you were unable to, or did not wish to, take part in 
Bowel scope screening”), were recorded for analysis. 
Qualitative Analysis  
All interviews were transcribed verbatim.  Interview transcripts and written responses 
were analysed using Thematic analysis. 
25
  After familiarising themselves with the data 
NH and LB initially worked independently then collaboratively to developed a data-
driven coding framework.    Once data were organised into codes, using word 
processing software, NH and LB searched for patterns and developed early themes, 
exploring similarities and differences between ‘screeners’ and ‘non-screeners’. These 
themes were reviewed for credibility by referring back to the empirical literature on 
screening behaviour. Peer validation was sought through sharing with the study steering 
group. This group comprised of clinicians and academics with expertise in screening 
research and a service user, with experience of FS screening and an interest in the bowel 
cancer screening programme.   
RESULTS  
We received a total of 214 sampling questionnaires (88 non-screeners; overall response 
rate 18%), 110 of whom agreed to be contacted for interview (32 non-screeners). 
Responses to the items on the sampling questionnaire indicated that the majority of 
screeners and non-screeners held positive beliefs about CRC screening (screeners 100% 
n=126; non-screeners 98% n=86). Many had concerns about the nature of the FS 
investigation (screeners 72% n=91; non-screeners 66% n=58).  Twenty eight people 
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who did not wish to be interviewed returned written responses and these data were 
analysed thematically in conjunction with interview data. No significant differences in 
responses to the items included on the sampling questionnaire were identified between 
those who agreed to be interviewed (n=104) and those who did not (n=110). There were 
demographic differences between the recruitment areas with 71% of respondents from 
the North East from areas within the two highest quintiles of indices of multiple 
deprivation in the UK compared with only 4% of those from the East of England. Table 
1 summarises the numbers of responses received and numbers of participants 
interviewed (screeners n=20; non screeners n=25). Appendix 1 and 2 provide a 
summary of the beliefs and attitudes of those interviewed towards screening along with 
key facilitators or barriers to attendance at the screening appointment. 
(Insert Table 1) 
Interview data and written comments demonstrated considerable heterogeneity in 
reported reasons for non-participation and multiple reasons were common. These are 
summarised in Figure 1 in relation to the stages of the programme invitation, separating 
the reasons for unwillingness and inability to be screened.  
(Insert Figure 1)  
The following section describes further in-depth exploration of the interview data in 
relation to the contexts, decision-making processes and emotional reactions rooted 
within the reasons provided for non-participation.  These centred primarily around the 
balancing of concerns in relation to the FS test and a potential cancer diagnosis, beliefs 
about the need for reassurance, conflicting priorities and practical issues in relation to 
appointment scheduling.    We use case examples (see table 2) as well as interview 
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quotations to illustrate the complexity of these processes and to highlight some typical 
experiences of non-screeners in relation to their non-participation.   
(insert table 2) 
Concerns and perceived risk: invasiveness, embarrassment and potential harm 
A general lack of awareness regarding the Bowel scope programme due to the early 
stage of national implementation at the time of our study meant that most interviewees 
with no prior experience or knowledge of endoscopic procedures described having 
reacted to their screening invitation with surprise or shock. The decision not to 
participate in screening for some had been based on a careful consideration of the 
perceived risks and harms associated with the test (see case study 1).  The anticipated 
“unpleasantness” of the FS procedure, associated both with its “invasiveness” and 
potential embarrassment for both screeners and non-screeners alike could however 
result in strong emotional reactions to the invitation (see case study 2). The FS test was 
described by some women as more intrusive and embarrassing than breast or cervical 
cancer screening, which were more easily normalised as part of being a “woman”.   
The information provided in the screening invitation relating to potential harm and, in 
particular, bowel puncture had caused additional concern and anxiety for some 
interviewees.    
“I read the bit which stuck in my head that it could puncture your bowel... and I 
thought oh right I’m not doing that… I was just too scared to have it done” (D-
60 Female non-screener) 
The bowel preparation (enema) was also described as a barrier.  These concerns often 
only became apparent after the initial decision to attend screening, as the implications 
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associated with the bowel preparation were not always clearly understood until further 
down the invitation process when the kit and instructions arrived through the post:  
“the only reason I cancelled my appointment was because after speaking to an 
assistant I realised I had to apply the enema an hour before attendance, … I 
could not do this at work. I would also feel worried about driving to the hospital 
after applying an enema!” (C-4 Female non-screener) 
 
Consideration of outcomes: Perceived need for reassurance and likelihood of a 
potential cancer diagnosis 
The anticipated unpleasantness of the procedures was often outweighed by strong 
beliefs about the personal need for reassurance offered by screening. It was the strength 
of perceived need for reassurance, rather than positive beliefs about the value of 
screening per se, that was more likely to be related to a rapid and/or firm decision to 
attend despite concerns about the procedure.  A commonly reported need to put up with 
the inconvenience, embarrassment and unpleasantness of the test was evident within the 
accounts of both screeners and the non-screeners who had wished to take part. 
However, the need for reassurance could override even intense anxiety about the 
procedure. 
 “Panic. I didn’t fancy this thing in my bum, but you’ve got to do it.  .. . I’ve got 
to do this for my peace of mind.”  (C-39 Male screener) 
Similarly, a strong, and potentially legitimate, perceived lack of need (for example, due 
to a recent endoscopic investigation, see case study 3) was more likely to result in a firm 
non-screening decision.   While the majority of interviewees, whether they had attended 
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or not, held positive attitudes towards population-based cancer screening in principle 
and acknowledged  the importance of early diagnosis, decision making was more likely 
to be based on assessments of their own personal perceived susceptibility to bowel 
cancer. For some people these beliefs were related to healthy behaviour choices or the 
presence of symptoms: 
“I do not feel at risk of bowel disease because I am not a heavy drinker, I hardly 
ever take pills and I have been vegetarian for 25 years and have an excellent 
diet and fitness regime,  But I still think it’s a great idea to offer this screening 
to people 55+” (D-63 Female non-screener) 
Personal experience of any type of cancer, either their own or of close others, seemed to 
heighten sensitivity to the need for reassurance and the importance of “catching cancer 
early” (see case study 4).  On the other hand, having witnessed suffering of a loved one 
after a long period of cancer treatment or remission could enhance fatalistic attitudes 
towards cancer.  
 “sometimes all these treatments and nothing works, so I think I would just give in at 
the first hurdle… they (friends with bowel cancer) went through all that battle and 
nothing worked” (D-60 Female non-screener). 
A preference not to know the outcome of screening was also described by those with 
existing physical and mental health conditions, particularly when associated with a 
reluctance to undergo treatment or a perceived inability to cope with the demands of a 
cancer diagnosis. Although there were some exceptions, most respondents’ accounts 
described their understanding of FS screening as a diagnostic tool rather than a 
preventive measure.   
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Responsibilities 
A common narrative in the interviews of both screeners and non-screeners was their 
sense of responsibility to take advantage of the screening opportunity. For some this 
included being accountable to the wider society, particularly in respect of the use of 
public (NHS) funding and resources, reporting an awareness that screening and early 
cancer detection was more cost effective than later treatment and a responsibility to 
maintain their own health.   However, appropriate use of resources was also described 
as a reason not to attend the Bowel scope appointment.   
 “I won't have treatment for cancer... So, you know, I just think I'm not wasting 
people’s, the NHS’s money or whatever, you know, I'm just not.” (D-83 Female 
non-screener) 
Competing priorities and chaotic lives 
Fitting in a screening appointment could be problematic when people were living 
chaotic lives, perhaps in deprived circumstances, caring for ill or disabled children or 
parents, or were faced with conflicting demands such as ill health.  Difficulties 
attending a screening appointment were exacerbated when there was a sense of not 
having any reserves left to deal with potentially negative outcomes, other more 
immediate health concerns, or there were practical issues administering the enema or 
getting to hospital.  The experiences of re-arranging inconvenient appointment times 
varied by screening centres, but the appointment system was a common barrier to many 
of those who had wished to take part and were unable to (see case study 4).  
Employment was another commonly reported competing priority. While appointments 
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were in the evening and at weekends, the need to request time off work to attend could 
be a major barrier, even for those who were positive about screening.   
Decision-making and future intention 
Although some interviewees reached a quick and firm decision about screening, 
decision-making was often described as a dynamic process and was more difficult when 
dissonant beliefs were held about potential screening outcomes and the need for 
screening.   
“if they found something, how would I react to that?  Well I might be better off 
not knowing.  But in the back of my mind that’s saying yeah but it’s better to 
know early.”  (C-112 Female non-screener) 
In these instances, decisions were reached with more difficulty and could change more 
easily and more frequently.   
“Many times I say no, I’m not going to do it, I don’t want to have that in  my 
body…one minute I was going yes, other minute I was  going no…it wasn’t an 
easy decision!” (C-39 Male screener) 
Seeking additional information and talking to others was also more likely in these 
instances.  Many non-screeners reported that they would consider taking part in 
screening in the future or had since decided to take part in FOBT screening when 
offered after their sixtieth birthday.   
 
DISCUSSION  
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This is the first qualitative study that we are aware of to explore the decision-making of 
people who have been invited to attend FS screening when offered as an organised 
population-based programme.  Our findings demonstrate that FS screening offered 
within this context is generally valued and associated with positive attitudes in relation 
to the importance of early diagnosis of cancer. These attitudes are held by those who do 
not attend screening as well as those who do.  Our in-depth exploration of the contexts, 
decision-making processes and emotional reactions rooted within the reasons provided 
for non-participation showed that these centre primarily around the balancing of 
concerns about the FS test and potential cancer diagnosis, beliefs about the personal 
need for screening and reassurance, conflicting priorities and practical issues in relation 
to appointment scheduling.  
The potential of FS screening to remove pre-cancerous polyps, thereby allowing cancer 
prevention as well as detection, was absent in many accounts from screeners and non-
screeners. When mentioned, this aspect of the screening was rarely described as having 
had a major influence on their decision making.   Our findings, nevertheless 
demonstrate that non-participation in FS screening is not necessarily due to a lack of 
knowledge, unjustified concerns or the lack of intention to attend an appointment. 
Furthermore, some participants felt their decision not to be screened was a rational and 
informed choice within the context of their individual circumstances.   
One of the strengths of our research is that we were able to compare a diverse range of 
accounts from screeners and non-screeners within and across research sites and 
screening centres, including from participants living in the most deprived areas within 
the UK.  Although our recruitment strategy, based on experience from a previous study,
 
14
  allowed for anticipated difficulties in recruiting non-screeners, the overall response 
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to our study invitation was low.  We were successful, nonetheless, in purposively 
sampling a diverse group of participants in terms of their beliefs, decision making and 
reasons for non-attendance.   We continued interviewing until data saturation was 
reached i.e. no new themes were emerging from additional accounts.   Our recruitment 
methods were based on qualitative purposive sampling.
24
  Further quantitative research 
would be required to ascertain the frequency of the different identified influences on  
decision-making within the wider population. The strength of our findings, however,  
lies within the in-depth  exploration of the range of processes and influences involved in 
screening behavior that is provided by our analysis of the accounts of our participants.   
Efforts were made to ensure that interviewees did not feel judged about their non-
attendance or coerced into future screening decisions. Although a degree of post-hoc 
rationalisation is possible, our impression was that participants provided open and 
honest accounts of their experiences. Our sample did not include enough respondents 
from ethnic minority groups to draw conclusions about more specific cultural 
influences
26
 and transferability of our findings to other regions and screening 
programmes may be limited. Despite including a mix of men and women and people 
from areas of high and low deprivation, we were not able to identify any influences 
specific to gender or deprivation. Further focused analysis in this area may, however, be 
of benefit, particularly as some of the barriers we identified including caring 
responsibilities, work practices and health benefits which are often gendered or socio-
culturally determined.    
Our study complements the findings of a previous qualitative study of non-participation 
nested within in the UK FS Trial, 
20
 as we were able to include and compare accounts of 
those with some intention to take part in FS screening but who were unable to, those for 
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whom screening was not necessary and those who had attended screening.  In contrast 
to their findings that practical barriers do not play a major role in screening uptake, we 
found that barriers, such as inability to attend the screening appointment do play a role 
and that these barriers have a greater influence on actual appointment attendance than 
the initial decision or intention to attend.  An analysis of variation in uptake during the 
first 14 months of the Bowel scope Screening programme
7
 identified that centre effects 
have an independent association with uptake along with deprivation and gender and that 
those offered out of hours appointments were more likely to attend screening.  Our 
participants’ experiences and satisfaction with re-arranging inconvenient appointment 
times differed between screening centres.  For some people, needing to request time off 
work to attend an appointment was seen to be embarrassing and was not always an 
appropriate option. Our study was completed in the early stages of the roll out of the 
Bowel scope programme when population and screening centre coverage was limited. 
Our findings indicate, however, that facilitation of uptake and satisfaction can be 
maximized by ensuring the flexibility of the appointment scheduling processes and 
accommodating those who would like to attend but are unable to when initially invited.   
Non-screeners who were undecided or unable to attend their initial invitation may 
benefit from an additional reminder at a later date. The integration of reminders into the 
screening programme has more recently also be shown by others to potentially be a 
feasible option worthy of further research.
27
  A more in-depth quantitative analysis on 
screening uptake, including data on how many people confirm, reschedule or cancel 
their appointment would be beneficial to ascertain the portion of non-screeners who 
may benefit from improved flexibility or a safety netting approach to appointment 
rescheduling. Implications on programme delivery would also need to be considered. At 
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present, Bowel scope clinic lists are ‘overbooked’ to accommodate non-attenders; a 
challenge for the programme is to balance service efficiency against capacity to 
maximize uptake while maintaining satisfaction with the appointment scheduling 
process and accommodating those who would like to attend but were unable to when 
initially invited.  
Our findings confirm the importance of the influence of the perceived burden of the FS 
test, identified by others. 
8, 12, 20,28 
   These concerns were evident across most 
participants, however, comparisons of accounts between screeners and non-screeners 
showed that when there is a strong perceived need for reassurance about potential 
cancer presence, concerns about the invasiveness of the test and other practical barriers 
were more readily overcome.  The concept of “perceived need for reassurance”, as 
described in our analysis, reflects an appraisal response to the activation of emotional 
reactions triggered by the screening invitation, specifically in relation to beliefs about 
personal risks and circumstances.  Our findings suggest that it is the strength of this 
perceived need rather than its presence that seems to be a crucial motivational driver of 
screening behavior.  It is directly influenced by beliefs about perceived personal 
susceptibility or vulnerability to cancer, coping style preferences, emotions and 
outcome expectancies (including fear and anxieties about the test itself, a potential 
cancer diagnosis and treatment), beliefs about screening and the socio-cultural context.  
“Perceived need for reassurance” therefore provides a useful lens through which to 
understand the decision-making process, as it allows for the involvement of a 
combination of existing socio-psychological constructs from health behavior theories 
that have been used to explain and predict screening uptake, such as, for example,  the 
extended Health Belief Model.
29
  Crucially, “perceived need for reassurance” also 
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allows for the influence of emotion on behavior and can be seen as being inextricably 
tied to the appraisal and coping processes that take place when faced with a health 
threat.
30
 The role of emotions and coping strategies in CRC screening behavior has been 
previously reported.  A questionnaire study of a subsample of the UK FS trial 
participants, for example, concluded that finding thoughts about cancer uncomfortable 
is associated with lower screening uptake and that different aspects of cancer fear can 
facilitate and inhibit screening intention and behavior in different ways. 
22
  The accounts 
from our participants illustrate and contextualise the strong emotions that can result 
from receiving a screening invitation associated with concerns not only about the 
screening process, but also with a potential cancer diagnosis and outcome expectancies 
associated with treatment beliefs and, for a small minority, general anxiety associated 
with hospital attendance. Our analysis also, therefore, complements findings by Oster et 
al 
31
 that people’s decisions to undergo CRC screening vary according to their degree of 
ambivalence towards finding out their cancer status  and concurs with Palmer et al. 
32
  
who propose that people do not wish to know the outcome of screening when they view 
treatment as "futile and unpleasant".  Anticipated regret, the decision to take action to 
avoid experiencing unpleasant emotions associated with not having acted in a particular 
way, is a more cognitive-based emotional influence on screening uptake that has been 
found to have a complex relationship with CRC screening behavior in a recent 
intervention study on FOBT screening
13
 and this is reflected within our participants’ 
accounts as an influence on their motivation to be screened.   
The reported relationship between the lack of abdominal complaints and lower uptake 
of CRC screening 
8, 28
 can also be explained within the context of a lower perceived 
need for reassurance.  Perceived susceptibility or vulnerability to a particular illness is 
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an important element of many theories used to explain health behaviours such as 
screening. 18,20  When illness beliefs are associated with a lower perceived susceptibility 
to cancer, the motivation to be screened may not be strong enough to overcome any 
associated concerns.  Within our participants’ accounts, this was linked to healthy 
lifestyle choices as well as symptoms. 
Our analysis demonstrates how decision-making processes in relation to FS screening 
are firmly situated within, and influenced by, the wider socio-cultural context of 
people's lives, particularly in relation to their previous experiences with, and/or family 
history of, cancer.   In the UK, uptake of colorectal cancer screening 
11,23 
 and more 
specifically for FS
 4, 7, 33 
is lower in areas of higher deprivation.   Further research is 
needed to explore the mediating effects of factors associated with higher deprivation 
such as existing physical and mental health problems (that may affect the desire and/or 
ability to attend the screening appointment), the lack of desire for potential treatment 
and lower flexibility in employment leave.  Difficulties assessing socio-cultural norms 
around FS screening behavior were commonly alluded to in our data, particularly for 
those with no prior experience or knowledge of endoscopic procedures.  As the Bowel 
scope programme extends and awareness increases, “normalisation” of FS screening 
may help to improve uptake 
32
 and positive experiences of the screening procedures will 
be important in this regard. The importance of information on how other people deal 
with particular situations has been highlighted by others 
34
 and some participants 
suggested that knowing about the screening experience of others would have been 
helpful.      
Cancer screening is often described in terms of a responsible or moral choice
10, 14, 35
.  
Our findings demonstrate that the moral responsibility to “catch cancer early” is a 
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common, and often dominant narrative.  Even when present, however, these beliefs do 
not necessarily result in screening uptake and in some instances,  non-participation in 
screening was also be explained in terms of moral choices and responsibilities, 
particularly within the context of wasting limited publically-funded health care 
resources. Finally, our analysis highlights the need to acknowledge the dynamic nature 
of decision-making and screening intention within future research.  Intention is often 
measured and reported as a relatively stable factor, however, our findings support a 
more variable stability of intention which should be taken into account when 
interpreting research findings in this area.  
 
 
CONCLUSIONS 
In-depth exploration of the contexts, decision-making processes and emotional reactions 
rooted within the reasons provided for non-participation highlight the need to recognise 
the heterogeinity of non-screeners, particularly in relation to whether they are unwilling 
or unable to attend screening.  Findings can inform the development and evaluation of 
targeted interventions and help to understand how psycho-social, provider and 
healthcare delivery factors interact to influence screening behavior.  
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Table 1 - Summary of responses 
 Male  
(East) 
Female 
(East) 
Male 
(North 
East) 
Female 
(North 
East) 
Total 
Total questionnaire 
responses 
 
55 70 34 55 214 
 
Qualitative  data Totals 
 
10 27 11 25 73 
 Written qualitative 
comments (non-screeners)  
2 11 4 11 28 
 In-depth Interviews (non-
screeners) 
3 11 3 8 25 
 In-depth interviews 
(screeners) 
5 5 4 6 20 
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Table 2 - Case Examples 
TYPICAL CASE EXAMPLES – NON-SCREENERS 
Case example 1:  Female non–screener (D-61) - Decision  not to be screened made 
based on consideration of harms and benefits.  
Eileen is a retired midwife/nurse who had lots of experience working within the 
NHS and dealing with screening related issues.  Her father died of bowel cancer 
years earlier and she described how he suffered for many years before he died.  
She thought very carefully about her response to the screening invitation and 
spoke to family members who encouraged her to attend, before calling to cancel 
her appointment.   She attends all other cancer screening programmes and feels 
that her decision-making process for Bowel scope was very different and more 
involved than for other types of screenings.   “The main thing that struck me was 
the statistics, you know one in 300 might have cancer, I though well I’m not having 
that shoved up my arse frankly for the sake of that, you know they might perforate my 
bowel.” She believes that finding bowel cancer early does not necessarily mean that 
you won’t die from it and is not convinced that the Bowel scope programme “can 
be remotely cost effective”. 
Case example 2: Male non-screener (D-34) – Believed it is a good thing to do, but 
unable to overcome concerns about nature of the investigation.  
Brian lives in a shared flat.  He was shocked at receiving the invitation and initially 
assumed it was related to ongoing medical investigations for cancer.  Once he 
realised this was not the case, he still felt this was something he probably should 
do, as “they probably screen people for a reason”.  He felt very anxious because of 
the intrusive nature of the test and he talked to his mother, daughter and friends at 
the pub about it.  They all encouraged him to take part.  He also looked up further 
information about the procedure on the internet.  After a long time deliberating, 
he decided he would go ahead with the screening, “grudgingly, I was kind of just 
thinking I would have it done”.  He had not realised that he needed to confirm his 
attendance and then received a letter saying it had been cancelled.  “At that point I 
thought relief to be honest and I decided to just leave it.”  He feels screening is a 
good thing, especially at his age, but had never considered bowel cancer before.  
His father has died of prostate cancer and Brian feels he would be more in need of 
prostate cancer screening.  “if nothing else I did read about it and it’s opened my 
eyes to bowel cancer, which I’d never thought about at all, so it probably did some 
good”.  He would encourage others to take part, but no longer has any intention to 
himself.  
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Case example  3:  Female  non-screener (C-71) - Bowel scope screening is currently 
unnecessary 
Barbara is retired and lives with her husband in a rural village.  Her invitation 
arrived just 6 weeks after she had undergone a sigmoidoscopy following a GP 
referral for loose stools and rectal bleeding.  “I am very much of the opinion that 
people should be responsible for their own health but to actually have the NHS just 
sort of knocking on your door and saying we’d like you to test this out for your peace 
of mind. I found it very welcome”.  She recently lost a close friend to bowel cancer 
and currently has 2 other friends undergoing treatment for bowel cancer.   After 
contacting the helpdesk she was advised FSFS was not required at the moment, 
but she intends to take up the offer of screening before her 60
th
 birthday as she is 
aware from her friends that the signs can be easily missed and she still has 
concerns “because of how I am normally, it might be a little bit difficult for me to 
actually isolate a change that’s abnormal”.   
 
Case example 4:   Female non-screener (D-44) - Desires to be screened but unable to 
attend  
Rose is a full-time carer for her father and disabled daughter. She has lost her 
mother and close relatives to bowel cancer and feels concerned about her risks.  
She had a screening colonoscopy five years earlier and initially believed this was a 
repeat appointment.  When she realised everyone was being invited for screening, 
she still wanted to take part.  She was unable to attend her allocated appointment 
time.  She has called twice to reschedule, but is unable to make an appointment far 
enough in advance to fit in with her caring responsibilities. “I can only go on these 
certain dates and they said well we can’t give you them dates because we can only go 
up to a fortnight or so many days.  I says well I can’t do it then and I was a bit 
annoyed about that… I rang back and they were filled up again, so I didn’t bother.” 
After that “I just forgot, I’ve got that much going on, I just forgot, that’s all”. She is 
still willing to undertake screening and thinks that she might try again, but is 
aware she may potentially receive a further surveillance appointment sometime in 
the future.   
 
 
